Cargando…

Clinically Relevant Oxygraphic Assay to Assess Mitochondrial Energy Metabolism in Acute Myeloid Leukemia Patients

SIMPLE SUMMARY: AML mitochondrial oxidative phosphorylation has recently been identified as a biological property that influences the response to antitumor therapy. In the present study, we propose a standardized protocol to measure mitochondrial metabolic organization in patient blasts (from the bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fovez, Quentin, Laine, William, Goursaud, Laure, Berthon, Celine, Germain, Nicolas, Degand, Claire, Sarry, Jean-Emmanuel, Quesnel, Bruno, Marchetti, Philippe, Kluza, Jerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699320/ https://www.ncbi.nlm.nih.gov/pubmed/34944972 http://dx.doi.org/10.3390/cancers13246353

Ejemplares similares

Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
por: Berthon, Celine, et al.
Publicado: (2020)

Lipid Metabolism and Resistance to Anticancer Treatment
por: Germain, Nicolas, et al.
Publicado: (2020)

Hereditary Predisposition to Acute Myeloid Leukemia in Older Adults
por: Fenwarth, Laurène, et al.
Publicado: (2021)

B7‐H3 protein expression in acute myeloid leukemia
por: Guery, Thomas, et al.
Publicado: (2015)

Stabilization protects islet integrity during respirometry in the Oroboros Oxygraph-2K analyzer
por: Crowder, Justin J., et al.
Publicado: (2022)

Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
por: Trinh, Anne, et al.
Publicado: (2021)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019)

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia
por: Boyer, Thomas, et al.
Publicado: (2016)

Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy
por: Winter, Marie, et al.
Publicado: (2023)

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
por: Stuani, Lucille, et al.
Publicado: (2019)

A New Strategy to Preserve and Assess Oxygen Consumption in Murine Tissues
por: Kluza, Jerome, et al.
Publicado: (2021)

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
por: Berthon, Céline, et al.
Publicado: (2010)

Dexamethasone in hyperleukocytic acute myeloid leukemia
por: Bertoli, Sarah, et al.
Publicado: (2018)

Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia
por: Larrue, Clement, et al.
Publicado: (2023)

Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia
por: Larrue, Clément, et al.
Publicado: (2019)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy
por: Cartel, Maëlle, et al.
Publicado: (2020)

RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage
por: Nugues, A-L, et al.
Publicado: (2014)

First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study
por: Germain, Nicolas, et al.
Publicado: (2019)

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia
por: Vergez, François, et al.
Publicado: (2022)

Inhibition of the proteasome and proteaphagy enhances apoptosis in FLT3‐ITD‐driven acute myeloid leukemia
por: Lopez‐Reyes, Rosa G., et al.
Publicado: (2020)

Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
por: Larrue, Clément, et al.
Publicado: (2021)

APR-246 induces early cell death by ferroptosis in acute myeloid leukemia
por: Birsen, Rudy, et al.
Publicado: (2021)

Stable Isotope Labeling Highlights Enhanced Fatty Acid and Lipid Metabolism in Human Acute Myeloid Leukemia
por: Stuani, Lucille, et al.
Publicado: (2018)

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia
por: Bertoli, Sarah, et al.
Publicado: (2015)

Put in a “Ca(2+)ll” to Acute Myeloid Leukemia
por: Lewuillon, Clara, et al.
Publicado: (2022)

p65/RelA NF‐κB fragments generated by RIPK3 activity regulate tumorigenicity, cell metabolism, and stemness characteristics
por: Touil, Yasmine, et al.
Publicado: (2021)

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
por: Debarri, Houria, et al.
Publicado: (2015)

Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia
por: Mouchel, Pierre-Luc, et al.
Publicado: (2020)

Quantitative Assay of Mutated Nucleophosmin in Acute Myeloid Leukemia
por: Khaled, Safaa A.A., et al.
Publicado: (2019)

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics
por: Marchetti, Philippe, et al.
Publicado: (2015)

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias
por: Paolillo, Rosa, et al.
Publicado: (2022)

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
por: Vasseur, Loïc, et al.
Publicado: (2023)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity
por: Mopin, Alexia, et al.
Publicado: (2022)

Vitamin C and D supplementation in acute myeloid leukemia
por: Mouchel, Pierre Luc, et al.
Publicado: (2023)

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023)

The prognostic relevance and expression of progranulin in adult patients with acute myeloid leukemia
por: Qin, Jiajia, et al.
Publicado: (2020)

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
por: Wang, Shi-sen, et al.
Publicado: (2021)

Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes
por: Paudel, B. Bishal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kbmu8akfblohht23rg56mim3r8